Triple combination of thymalfasin, peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior interferon and ribavirin treatment: 24-week interim results of a pilot study. [electronic resource]
Producer: 20080320Description: S79-81 p. digitalISSN:- 1440-1746
- Adult
- Antiviral Agents -- therapeutic use
- Drug Therapy, Combination
- Female
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- drug therapy
- Humans
- Interferon alpha-2
- Interferon-alpha -- therapeutic use
- Male
- Mexico
- Middle Aged
- Pilot Projects
- Polyethylene Glycols -- therapeutic use
- RNA, Viral -- blood
- Recombinant Proteins
- Ribavirin -- therapeutic use
- Thymalfasin
- Thymosin -- analogs & derivatives
- Time Factors
- Treatment Failure
- Treatment Outcome
- Viral Load
- Virus Replication -- drug effects
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.